512
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Cost-effectiveness of asthma therapy

, MBBCh, DCH, FCPaed, DTM&H, MMed, FCCP, PhD, Dip Allerg(SA) (Associate Professor, Paediatric Pulmonologist)
Pages 44-47 | Published online: 15 Aug 2014

References

  • Green RJ, Cost-effective management of asthma in children. Curr Allergy Clin Immunol 2004; 17: 12–16
  • Sullivan S, Elixhauser A, Buist AS, Luce BR, Eisenberg J, Weiss KB. National Asthma Education and Prevention Program Working Group report on the cost-effectiveness of asthma care. Am J Respir Crit Care Med 1996; 154: 84S–95S.
  • Sullivan SD. Economics of asthma and asthma treatments. Eur Respir Rev 1998; 8: 351–355.
  • Warner KE, Luce BR. Cost-benefit and Cost- Effectiveness Analysis in Health Care: Principles, Practice and Potential. Ann Arbor, MI: Health Administration Press, 1982.
  • Weinstein MC, Stason WB. Foundations of cost—effectiveness analysis for health and medical practices. N Engl J Med 1977; 296: 716–721.
  • Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J 1996; 9: 636–642.
  • Global Initiative for Asthma. Available at www.ginasthma.com. Accessed August 1, 2005
  • Ordonez G, Phelan PD, Olinsky A, et al. Preventable factors in hospital admissions for asthma. Arch Dis Child 1998; 78: 143–147
  • Hartert TV, Windom HH, Peebles RSJr, et al. Inadequate outpatients medical therapy for patients with asthma admitted to two urban hospitals. Am J Med 1996; 100: 386–394
  • Jacobson L, Hertzman P, Lofdahl CG, et al. The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991. Respir Med 2000; 94: 247–255
  • Szucs TD, Anderhub H, Rutishauser M. The economic burden of asthma: direct and indirect costs in Switzerland. Eur Respir J 1999; 13: 281–286
  • Smith DH, Malone DC, Lawson KA, et al. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997; 156: 787–793
  • Lozano P, Sullivan SD, Smith DH, et al. The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol 1999; 104: 957–963
  • Bisgaard H, Moller H. Changes in risk of hospital readmission among asthmatic children in Denmark, 1978–93. BMJ 1999; 319: 229–230
  • Jonasson G, Lodrup Carlsen KC, Leegaard J, et al. Trends in hospital admissions for childhood asthma in Oslo, Norway, 1980–95. Allergy 2000; 55: 232–239
  • Wennergren G, Kristjansson S, Strannegard IL. Decrease in hospitalization for treatment of childhood asthma with increased use of anti-inflammatory treatment, despite an increase in prevalence of asthma. J Allergy Clin Immunol 1996; 97: 742–748
  • Antonicelli L, Bucca C, Neri M, et al. Asthma severity and medical resource utilisation. Eur Respir J 2004; 23: 723–9
  • Sazonov Kocevar V, Jonsson L, Valovirta E, Thomas JIII, Kristensen F, Messonnier M, Bisgaard H. Inpatient cost among pediatric patients with asthma in four Nordic Countries. ECACI 2001 (abstract)
  • Laforest L, Yin D, Kocevar VS, Pacheco Y, Dickson N, Gormand F. Association between asthma control in children and loss of workdays by caregivers. Ann Allergy Asthma Immunol 2004; 93: 265–71
  • Trautner C, Richter B, Berger M. Cost-effectiveness of a structured treatment and teaching programme on asthma. Eur Respir J 1993; 6: 1485–1491.
  • Asperen PV, Jandera E, Neef JD, Hill P, Law N. Education in childhood asthma. A preliminary study of need and efficacy. Aust Paediatr J 1986; 22: 49–52.
  • Becis M, Taylor B. What do schoolteachers know about asthma? Arch Dis Child 1990; 65: 622–625.
  • Luyt DK, Green RJ, Davis G, et al. Allergic rhinitis in South Africa—diagnosis and management. S Afr Med J 1996; 86 (part 2): 1313–1328.
  • Total Private Market Report. (Pharmaceutical Market South Africa). Intercontinental Medical Statistics 1997; Dec: 223.
  • Spector S. Non compliance with asthma therapy—are there solution? J Asthma 2000; 37(5): 381–88
  • Davies GM, Dasbach EJ, Santanello NC, Knorr BA, Bratton DL. The effect of Montelukast vs usual care on healthcare resource utilization in children 2–5 years of age with asthma. Clin Ther 2004; 26: 1895–904
  • Travier et al. Asthma II Study: Children. Data on file. Merck, USA
  • Anstatt DT, Allen-Ramey FC, Korelitz JJ, Bethel J, Sajjan S, Markson LE. Asthma Control with Montelukast or Salmeterol As Add-On Therapy to Inhaled Corticosteroid Treatment of Asthma. Data on file. Merck, USA
  • Guest JF, Davie AM, Ruiz FJ, Greener MJ. Switching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costs. Prim Care Respir J 2005; in press